Welcome to the Department of Internal Medicine Research
William J Calhoun MD
Vice Chair for Research
The Department of Internal Medicine is actively involved in a variety of research efforts, from human clinical trials using innovative medications, to basic bench research directed towards discovering fundamental mechanisms of chronic disease. An important effort of Internal Medicine faculty is translational research, the application of cutting-edge science to clinical problems and their solutions (link to ITS website here).
In FY 2010, we had 94 awards, totaling about $25 million, about half of which was federal support. We increased research awards, and research expenditures, from FY 2009.
The Department supports a MultiDisciplinary Clinical Trials Office [CTO] jointly with the Department of Ophthalmology and Visual Sciences [OVS], directed by Dr Calhoun, and Managed by Lisa Nemeth Sweeny RN. It is staffed with clinical research nurses and clinical coordinators, has equipment and furnishings for patient interventions common in clinical trials, and occupies space on the third floor of the OVS building at 700 University Avenue. Stop by to see our facilties!
An important research initiative in our Department is the development of Interest Clusters. Our purpose for the Interest Clusters is to bring together clinicians, clinical scientists, and basic scientists who share interests in a disease or process, in order to facilitate new research opportunities. We currently have four such clusters:
- Mucosal Immunology: Tor Savidge PhD, Cluster Leader
- Complications of Diabetes: Ron Tilton PhD, Cluster Leader
- Outcomes Research: Jean Freeman PhD, Gulshan Sharma MD, Cluster Co-Leaders
- Immunology and Immunoregulation: Silvia Pierangeli PhD, Cluster Leader
Contact the Cluster Leader, or Dr Calhoun, if you would like more information, or to become involved. Our web page is under active development. Stop by frequently to see the latest updates.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.